Similar Articles
1291 Management of hepatocellular carcinoma: Enlightening the gray zones
1292 Non-viral factors contributing to hepatocellular carcinoma
1293 Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus
1294 Coadministration of telaprevir and transcatheter arterial chemoembolization in hepatitis C virus-associated hepatocellular carcinoma
1295 Hepatocellular carcinoma: Clinical study of long-term survival and choice of treatment modalities
1296 Controversy over the use of intraoperative blood salvage autotransfusion during liver transplantation for hepatocellular carcinoma patients
1297 Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma
1298 Perceptions about preventing hepatocellular carcinoma among patients with chronic hepatitis in Taiwan
1299 Transarterial embolization of metastatic mediastinal hepatocellular carcinoma
1300 Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA